Processa Pharmaceuticals Inc — Quarterly Balance Sheet (NASDAQ:PCSA)

Financials

Total revenue ————— — Gross profit ————— — Operating expenses 1.14 M1.02 M1.26 M1.5 M1.83 M 5.61 M Selling/general/admin expenses 1.14 M1.02 M1.26 M1.5 M1.83 M 5.61 M Research & development 2.29 M1.71 M1.59 M2.45 M1.66 M 7.41 M Operating income -3.42 M-2.73 M-2.85 M-3.95 M-3.49 M -13.02 M Non-Operating Income, Total 40.15 K—12.58 K16.87 K52.27 K — Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 40.15 K—000 — Unusual income/expense ——12.58 K16.87 K52.27 K — Pretax income -3.38 M-2.73 M-2.83 M-3.93 M-3.44 M -12.94 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -3.38 M21.02 M2.8 M-3.93 M-3.44 M 16.45 M Discontinued operations ————— — Net income -3.38 M21.02 M2.8 M-3.93 M-3.44 M 16.45 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -3.38 M-2.73 M-2.83 M-3.93 M-3.44 M -12.93 M Basic earnings per share (Basic EPS) -25.75-18-7.5-6.25-1.75 -33.5 Diluted earnings per share (Diluted EPS) -25.75-18-7.5-6.25-1.75 -33.5 Average basic shares outstanding 131.04 K122.4 K381.07 K622.77 K1.9 M 3.03 M Diluted shares outstanding 131.04 K122.4 K381.07 K622.77 K1.9 M 3.03 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 203301301301301 1 204